title: [Arf6, RalA and BIRC5 protein expression in non small cell lung cancer].
abstract: Evaluation of tumor markers expression pattern which determines individual progression parameters is one of the major topics in molecular oncopathology research. This work presents research on expression analysis of several Ras-Ral associated signal transduction pathway proteins (Arf6, RalA and BIRC5) in accordance with clinical criteria in non small cell lung cancer patients. Using Western-blot analysis and RT-PCR Arf6, RalA and BIRC5 expression has been analyzed in parallel in 53 non small cell lung cancer samples of different origin. Arf6 protein expression was elevated in 55% non small cell lung cancer tumor samples in comparison with normal tissue. In the group of squamous cell lung cancer Arf6 expression elevation was observed more often. RalA protein expression was decreased in comparison to normal tissue samples in 64% of non small cell lung cancer regardless to morphological structure. Correlation between RalA protein expression decrease and absence of regional metastases was revealed for squamous cell lung cancer. BIRC5 protein expression in tumor samples versus corresponding normal tissue was 1.3 times more often elevated in the squamous cell lung cancer group (in 76% tumor samples). At the same time elevation of BIRC5 expression was fixed only in 63% of adenocarcinoma tumor samples. A statistically significant decrease (p = 0.0158) of RalA protein expression and increase (p = 0.0498) of Arf6 protein expression in comparison with normal tissue was found for T1-2N0M0 and T1-2N1-2M0 groups of squamous cell lung cancer correspondingly.
authors.forename: A V
authors.initials: AV
authors.lastname: Knizhnik
authors.forename: O B
authors.initials: OB
authors.lastname: Kovaleva
authors.forename: K K
authors.initials: KK
authors.lastname: Laktionov
authors.forename: V V
authors.initials: VV
authors.lastname: Mochal'nikova
authors.forename: A V
authors.initials: AV
authors.lastname: Komel'kov
authors.forename: E M
authors.initials: EM
authors.lastname: Chevkina
authors.forename: I B
authors.initials: IB
authors.lastname: Zborovskaia
mesh_terms: D000089982:ADP-Ribosylation Factor 6; D020727:ADP-Ribosylation Factors / Q000096:biosynthesis* / Q000235:genetics; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism / Q000473:pathology*; D015870:Gene Expression / Q000235:genetics; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000096:biosynthesis* / Q000235:genetics; D008175:Lung Neoplasms / Q000378:metabolism / Q000473:pathology*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D000077022:Survivin; D020725:ral GTP-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D000089982:ADP-Ribosylation Factor 6; C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D000077022:Survivin; C492198:RALA protein, human; D020727:ADP-Ribosylation Factors; C000715348:ARF6 protein, human; D020725:ral GTP-Binding Proteins